SCHEMBL4900312

SCHEMBL4900312

O=C(O)N1CCC(C(=O)NCC(O)c2ccccc2)(c2ccc(Br)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.42
BCAT2 O15382 1/20 0.42
KDM4E B2RXH2 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
TRPA1 O75762 4/20 0.40
ACE2 Q9BYF1 1/20 0.40
ATM Q13315 1/20 0.40
OPRM1 P35372 2/20 0.39
OPRL1 P41146 2/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CCR1 P32246 1/20 0.39
HTT P42858 1/20 0.38
MEN1 O00255 1/20 0.38
IGF1R P08069 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4896138 0.80 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1ACE2OPRL1LMNA
SCHEMBL4963420 0.77 TRPA1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1BCAT2
SCHEMBL4963409 0.77 TRPA1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1BCAT2
SCHEMBL2471156 0.67 TSHR (0.48) NPC1SMN1; SMN2ALDH1A1OPRM1OPRL1
SCHEMBL1427539 0.66 CA12 (0.57) ALDH1A1ACE2OPRM1OPRL1OPRD1
Hydrochloric Acid SCHEMBL433923 0.66 HSD11B1 (0.49) SMN1; SMN2ALDH1A1KDM4EOPRL1LMNA
SCHEMBL13403151 0.66 BCAT2 (0.47) NPC1RAB9ASMN1; SMN2BCAT2KDM4E
SCHEMBL23779147 0.66 KMT2A (0.69) RAB9AMEN1KMT2A
SCHEMBL1554808 0.66 BCAT2 (0.51) NPC1RAB9ASMN1; SMN2BCAT2KDM4E
SCHEMBL17373696 0.66 BCAT2 (0.51) NPC1RAB9ASMN1; SMN2BCAT2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed